164P Efficacy and safety of anlotinib plus toripalimab as first-line regimen in advanced gastric cancer patients with performance status 2 (PS 2): An open-label, single arm, phase II trial
医学
打开标签
养生
肿瘤科
癌症
临床研究阶段
内科学
外科
临床试验
作者
K Liu,Botao Qin,S. J. Chen,X. Zhong,Xinwang Duan,Yuqiang Wu,Ling Ye,Lei Sun,Duojia Shi,Xiao‐Dong Jiao,Yingzhuo Zang